Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Lomir SRO°

Lomir SRO° :
Type Medicine Withdrawn
Originator B
Agent Khalil Fattal & Fils
Distributor Khalil Fattal & Fils
Laboratory Novartis
Responsible Party Novartis Pharma AG
Origin Switzerland
Manufacturer Novartis Farmaceutica SA
Origin Spain
ATC C08CA03

Your comment will appear shortly after approval

Lomir SRO° :

Revision Date : 01/05/2011


Effect Frequency
Abdominal discomfort Common
Allergic reaction Very rare
Anaemia Very rare
Anaphylactic reactions Very rare
Angina pectoris Very rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Very rare
Anorexia Very rare
Anxiety Very rare
Appetite lost Very rare
Arthralgia (Pain joint) (Joint ache) Very rare
Asthenia Very rare
Atrial fibrillation Very rare
Back pain Very rare
Bradycardia Very rare
Cardiac failure Very rare
Cephalea Very Common
Cerebrovascular accident Not known
Chest pain Not known
Constipation Not known
Cough Very rare
Depression Very rare
Diarrhoea (Diarrhea) Not known
Dizziness Common
Dry mouth (Xerostomia) Not known
Dyspnoea (dyspnea) Common
Erectile dysfunction Very rare
Fatigue Common
Flushing skin Very Common
Gingival hyperplasia Very rare
Gynecomastia (Gynaecomastia) Very rare
Hepatitis Very rare
Hypersensitivity reactions Very rare
Hypoesthesia Very rare
Hypotension Uncommon
Insomnia Not known
Lethargy Not known
Leucopenia (Leukopenia) Very rare
Liver function test abnormal Very rare
Malaise Common
Muscle cramps Very rare
Myocardial infarction Very rare
Nausea Very rare
Nervousness Very rare
Oedema peripheral Very Common
Pain in extremity (Pain in limb) Very rare
Palpitations Common
Paraesthesia (paresthesia) Very rare
Photosensitivity Very rare
Polyuria Common
Pruritus Very rare
Skin rash Common
Somnolence Very rare
Sweating Very rare
Syncope Not known
Tachycardia Common
Thrombocytopenia (Thrombopenia) Very rare
Transaminases increased Very rare
Transient ischaemic attack Not known
Ventricular arrhythmia Very rare
Vision blurred Very rare
Visual disturbance Very rare
Vomiting Very rare
Weight increased (weight gain) Uncommon

Different Units By MoH Code

Revision Date : 21/01/2000

Revision Date : 27/06/2007

Lomir SRO°  MoH 859 :
Form Capsule, hard
Package Size Box of 30
Strength 5mg
Stratum N/A
NSSF ✘
Quarantine ✘
Reg. Number 27814
Submission date 01/01/1994
Registration Year 1994
Archived Date 2014
Withdrawn Date 04/05/2021


Price Comparison

● Country: Switzerland
● Package Size: 30
● Public Price: 34.9 CHF ( 3,609,358.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 1,1633 CHF ( 103,420.00 LBP )
● Exfactory Price: 16.11 CHF
● Pricing Date: 20/06/2019
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 30
● Public Price: 77 AED ( 1,860,397.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 2,5667 AED ( 48,322.00 LBP )
● Pharmacy Price: 62.04 AED ( 1498948.44 LBP )
● Pricing Date: 16/11/2019
● Type: Medicine Authorised

● Country: KSA
● Package Size: 30
● Public Price: 69.75 SAR ( 1,648,890.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 2,325 SAR ( 47,280.00 LBP )
● Reference: sfda
● Pricing Date: 05/03/2020
● Type: Medicine Non Marketed

● Country: The Netherlands
● Package Size: 30
● Public Price: 19.45 EUR ( 1,884,238.20 LBP )
● Pack size unit used: 30
● Cost/Unit: 0,6483 EUR ( 0.00 LBP )
● Pharmacy Price: 12.45 EUR ( 1206106.2 LBP )
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Authorised

● Country: Cyprus
● Package Size: 30 CAPS
● Public Price: 13.6 EUR ( 1,317,513.60 LBP )
● Pack size unit used: 30
● Cost/Unit: 0,4533 EUR ( 0.00 LBP )
● Reference: Cyprus Minister of Health
● Pricing Date: 02/11/2018
● Type: Medicine Non Marketed

● Country: Belgium
● Package Size: 30
● Public Price: 19.22 EUR ( 1,861,956.72 LBP )
● Pack size unit used: 30
● Cost/Unit: 0,6407 EUR ( 0.00 LBP )
● Reference: cbip
● Pricing Date: 27/11/2020
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info